Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Obstructive Lung Diseases

Free Subscription 08.09.2025 3 Allergy 3 Ann Allergy Asthma Immunol 4 Arch Bronconeumol 1 Chest 1 J Allergy Clin Immunol 6 J Asthma 4 Pediatr Allergy Immunol 1 Pediatrics 1 PLoS One 15 Respir Med 1 Respir Res 2 Rev Mal Respir 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Allergy

1. HAN A, Deng S, Wang S, Zheng J, et al
   The Uneven Risks of Childhood Asthma Under Extreme Temperatures and Its Interactions With Environmental Factors.
   Allergy. 2025 Sep 5. doi: 10.1111/all.70023.
   PubMed        
   
   
2. CAVALEIRO RUFO J, Paciencia I, Jutel M, Moreira A, et al
   The Impact of War on Asthma, a Systematic Review and Meta-Analysis: An EAACI Task Force Report.
   Allergy. 2025 Sep 4. doi: 10.1111/all.70038.
   PubMed         Abstract available
   
   
3. HUANG HJ, Breyer-Kohansal R, Niespodziana K, Lim CJM, et al
   Molecular IgE Sensitization Profiling With Micro-Arrayed Allergen Molecules in Adult Patients With Asthma From the LEAD Cohort: A Precision Medicine Approach.
   Allergy. 2025 Aug 30. doi: 10.1111/all.70017.
   PubMed         Abstract available
   
   

   
   Ann Allergy Asthma Immunol

4. JHANG YS, Chang HC, Gau SY
   Risk of asthma in US adults with COVID-19 in real-world settings.
   Ann Allergy Asthma Immunol. 2025;135:347-348.
   PubMed        
   
   
5. ABDELKADER S, Voladri DR, Kennedy JL
   Beyond respiratory syncytial virus and rhinovirus: The other viral respiratory bandits.
   Ann Allergy Asthma Immunol. 2025;135:249-260.
   PubMed         Abstract available
   
   
6. PATERSON F, On JY, Ahmed D, Poto R, et al
   Real-life evaluation of novel forced expiratory ratios with asthma exacerbations and symptoms.
   Ann Allergy Asthma Immunol. 2025 Aug 29:S1081-1206(25)00440.
   PubMed         Abstract available
   
   

   
   Arch Bronconeumol

7. CHANG Q, Zhu Y, Liang H, Liu B, et al
   Association of Plasma Metabolic Profiling With Asthma Phenotypes and Exacerbation.
   Arch Bronconeumol. 2025 Jul 29:S0300-2896(25)00268.
   PubMed        
   
   
8. ZHOU Y, Wu F, Li H, Deng Z, et al
   Effect of Carbocysteine on Exacerbations and Lung Function in Patients With Mild-to-Moderate Chronic Obstructive Pulmonary Disease: A Multicentre, Double-Blind, Randomized, Placebo-Controlled Trial.
   Arch Bronconeumol. 2025;61:528-535.
   PubMed         Abstract available
   
   
9. PADILLA JM, Alfaro E, Casitas R, Galera R, et al
   Characterization of Inactive COPD Patients: Barriers to Physical Activity and Perceived Impact of Inactivity.
   Arch Bronconeumol. 2025;61:555-563.
   PubMed         Abstract available
   
   
10. SAYAS CATALAN J, Lalmolda C, Hernandez-Voth A, Corral Blanco M, et al
    Thoracoabdominal Asynchrony in Very Severe COPD: Clinical and Functional Correlates During Exercise.
    Arch Bronconeumol. 2025;61:544-554.
    PubMed         Abstract available
    
    

    
    Chest

11. NOBLE JH, Warhurst S, Cullen R, Sayers R, et al
    THE DOSE-RESPONSE OF INHALED CORTICOSTEROIDS IN COMBINATION ICS/LABA MAINTENANCE THERAPY FOR ASTHMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Chest. 2025 Sep 3:S0012-3692(25)05145-1. doi: 10.1016/j.chest.2025.
    PubMed         Abstract available
    
    

    
    J Allergy Clin Immunol

12. VISNESS CM, Sorkness CA, Sorkness R, Gergen PJ, et al
    Impact of race-based spirometry equations on guideline-based asthma management in clinical trials.
    J Allergy Clin Immunol. 2025 Aug 28:S0091-6749(25)00894.
    PubMed         Abstract available
    
    

    
    J Asthma

13. MAHESHWARI A, De S
    Oscillometry-defined small airway dysfunction in steroid-naive adult bronchial asthma: association with eosinophilic and non-eosinophilic phenotypes.
    J Asthma. 2025 Sep 5:1-7. doi: 10.1080/02770903.2025.2552737.
    PubMed         Abstract available
    
    
14. ZHOU X, Zhou Y, Chen J, Chen C, et al
    Dietary antioxidants: a challenge or an opportunity for asthma? Genetic Insights from a Two-sample Mendelian Randomization Study.
    J Asthma. 2025 Sep 5:1-15. doi: 10.1080/02770903.2025.2555297.
    PubMed         Abstract available
    
    
15. MA S, Hu W, Bi Y, Han Y, et al
    Exploring the causal role of plasma metabolites in pediatric asthma: a Mendelian randomization study.
    J Asthma. 2025 Sep 5:1-14. doi: 10.1080/02770903.2025.2552748.
    PubMed         Abstract available
    
    
16. MIAO Y, Chen H, Wei Q, Yan K, et al
    Circulating Inflammatory Proteins as Causal Drivers and Therapeutic Targets in Asthma: Insights from Genetic and Pathway-Based Analyses.
    J Asthma. 2025 Aug 31:1-19. doi: 10.1080/02770903.2025.2555292.
    PubMed         Abstract available
    
    
17. POLU PR, Bikki VK
    Asthma Endotypes in Flux: Integrating Type 1 and Type 2 Inflammation for Biological Therapy Advancement.
    J Asthma. 2025 Aug 30:1-29. doi: 10.1080/02770903.2025.2555300.
    PubMed         Abstract available
    
    
18. LEUNG W, Hubbard M, Lee J, Kim M, et al
    Physical Activity Levels in Individuals with Asthma: A Comparison Between Wearable Device Users and Non-Users: 2017 BRFSS.
    J Asthma. 2025 Aug 30:1-12. doi: 10.1080/02770903.2025.2555301.
    PubMed         Abstract available
    
    

    
    Pediatr Allergy Immunol

19. CINICOLA BL, Eigenmann P, Genuneit J
    Editorial comment on "Neonatal BCG vaccination to prevent asthma: Results from the MIS BAIR randomized controlled trial".
    Pediatr Allergy Immunol. 2025;36:e70180.
    PubMed        
    
    
20. MANELL H, Stenlid R, Alving K
    Asthma diagnosis is not associated with reduced beta-cell function in children and adolescents with obesity.
    Pediatr Allergy Immunol. 2025;36:e70198.
    PubMed        
    
    
21. EL DIDI HS, Pereira AM, Jacome C, Amaral R, et al
    Control of Allergic Rhinitis and Asthma Test for Children (CARATkids): A systematic review and meta-analysis of its measurement properties.
    Pediatr Allergy Immunol. 2025;36:e70191.
    PubMed         Abstract available
    
    
22. FYOLEK JP, Mahdavinia M, Jiang J, Bilaver LA, et al
    Distinct skin microbiome signatures in Black and White children with food allergy and asthma.
    Pediatr Allergy Immunol. 2025;36:e70197.
    PubMed        
    
    

    
    Pediatrics

23. CHEUNG CR, Butler M, Cooper C, Dhanoa H, et al
    Using Artificial Intelligence and Machine Learning to Promote Child Health Equity.
    Pediatrics. 2025;156.
    PubMed         Abstract available
    
    

    
    PLoS One

24. REIMER J, Page J, Saha P, Shen S, et al
    Leveraging dynamic stability to infer regulation in protein-protein interaction networks: A study of infectious vulnerability in COPD.
    PLoS One. 2025;20:e0326062.
    PubMed         Abstract available
    
    

    
    Respir Med

25. HARVEY ES, Hamada Y, Hiles SA, Langton D, et al
    Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry.
    Respir Med. 2025 Sep 3:108340. doi: 10.1016/j.rmed.2025.108340.
    PubMed         Abstract available
    
    
26. BUENDIA JA, Manrique Acevedo LF, Celis Preciado C
    "Beyond triple Therapy: Is dupilumab a cost-effective option for COPD with type 2 inflammation?".
    Respir Med. 2025;247:108254.
    PubMed         Abstract available
    
    
27. EGGLESTON RH, Torghabeh MH, Niven AS, Lim KG, et al
    Bronchodilator Response: Utility and implications in patients undergoing hematopoietic stem cell transplantation.
    Respir Med. 2025;247:108259.
    PubMed         Abstract available
    
    
28. VERMA B, Kumar N, Ashique S, Debnath B, et al
    Probiotics: An adjuvant treatment strategy for chronic respiratory diseases.
    Respir Med. 2025;247:108268.
    PubMed         Abstract available
    
    
29. SHAHID H, Ahmed M, Sami SZ, Kumar S, et al
    High-intensity versus low-intensity non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2025;247:108277.
    PubMed         Abstract available
    
    
30. VILLAR-AGUILAR L, Casal-Guisande M, Fernandez-Villar A, Garcia-Rodriguez E, et al
    Characterisation of patients with Alpha-1 antitrypsin deficiency using unsupervised machine learning tools.
    Respir Med. 2025;247:108278.
    PubMed         Abstract available
    
    
31. BECK DA SILVA ETGES AP, Marcolino MAZ, Bianchini L, Kawano-Dourado L, et al
    Economic analysis of high-flow nasal oxygen compared with noninvasive ventilation in patients with acute respiratory failure: results from the RENOVATE randomized clinical trial.
    Respir Med. 2025;247:108270.
    PubMed         Abstract available
    
    
32. NIEDERMAIER T, Alter P, Jorres R, Vogelmeier C, et al
    Parametric estimation of age-, sex-, and spirometry grade-specific mortality in a cohort of COPD patients from Germany: Results from COSYCONET.
    Respir Med. 2025;247:108280.
    PubMed         Abstract available
    
    
33. DU BERRY C, Simpson SJ, Spittle AJ, Holland AE, et al
    Exercise training to address lifelong consequences of preterm birth: a survey of perceived needs.
    Respir Med. 2025;247:108284.
    PubMed         Abstract available
    
    
34. CANDIA C, Fuschillo S, Ambrosino P, Motta A, et al
    Exercise-based pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease: What is the potential role of biomarkers? A narrative review.
    Respir Med. 2025;247:108282.
    PubMed         Abstract available
    
    
35. CAZZOLA M, Maniscalco M, Patella V, Calzetta L, et al
    Comparing major COPD triple therapy trials using a structured multi-criteria decision analysis: A deep dive into patient populations and outcomes.
    Respir Med. 2025;247:108292.
    PubMed         Abstract available
    
    
36. CAI S, Huang Q, Huang M, Wang J, et al
    Association of aspirin use with mortality in critically ill patients with chronic obstructive pulmonary disease: A retrospective propensity score-matched cohort study.
    Respir Med. 2025;247:108300.
    PubMed         Abstract available
    
    
37. DETTORAKI M, Vandorou KT, Tsoukalas D, Basagianni E, et al
    Ocular manifestations in COPD patients. An underrecognized comorbidity.
    Respir Med. 2025;247:108313.
    PubMed         Abstract available
    
    
38. MURAOKA H, Tsuburai T, Komase Y, Tanaka S, et al
    Association between 6-min walk test and initiation of home oxygen therapy within 3 years in chronic obstructive pulmonary disease managed by primary care physicians.
    Respir Med. 2025;247:108317.
    PubMed         Abstract available
    
    
39. CELEBI SOZENER Z, Ozdel Ozturk B, Sahinoglu E, Koyluce S, et al
    Benralizumab In Severe Eosinophilic Asthma: A Real-Life Data From Turkiye.
    Respir Med. 2025 Aug 28:108332. doi: 10.1016/j.rmed.2025.108332.
    PubMed         Abstract available
    
    

    
    Respir Res

40. YUAN D, Yang X, He B, Han Y, et al
    Yanghe Pingchuan granules inhibit cellular senescence in airway smooth muscle cells to improve bronchial asthma via modulating Nrf2 acetylation.
    Respir Res. 2025;26:266.
    PubMed         Abstract available
    
    

    
    Rev Mal Respir

41. LEJEUNE S, Wanin S, Amat F, Lezmi G, et al
    [Guidelines from the SP2A (Pediatric Society of Pulmonology and Allergology) for the management of asthma in children aged 6 to 12years (without management of asthma exacerbation) - Short version].
    Rev Mal Respir. 2025 Aug 29:S0761-8425(25)00209.
    PubMed        
    
    
42. AGUILANIU B, Cittee J, Watier L, Pribil C, et al
    [Use of fluticasone/umeclidinium/vilanterol in France: A population based study].
    Rev Mal Respir. 2025;42:331-342.
    PubMed         Abstract available
    
    

    
    Thorax

43. SYKES DL, Clarkson MD, Negbenebor A, Cummings H, et al
    Impact of regional asthma guidelines on SABA prescribing patterns across England: an interrupted time series analysis.
    Thorax. 2025 Sep 2:thorax-2025-223239. doi: 10.1136/thorax-2025-223239.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.